Search for: "C. & R. RESEARCH CORPORATION v. Write"
Results 81 - 100
of 139
Sorted by Relevance
|
Sort by Date
8 Apr 2024, 10:08 am
As a practical matter, the burden shifts to the party that wishes to challenge the relied upon facts and data to learn more about the cited studies to show that the facts and data are not sufficient under Rule 702(b), and that the testimony is not the product of reliable methods under Rule 702(c). [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent revoked by… [read post]
2 Dec 2010, 9:16 am
Foster.Foster, James C. [read post]
24 Nov 2010, 11:44 am
and Bob Ney (R-Ohio). [read post]
3 Mar 2010, 7:33 pm
From 1979-2009, total license fees paid by cable & satellite companies to support C-SPAN totaled $922 million. [read post]
14 Mar 2011, 1:55 pm
Maryland and Giglio v. [read post]
2 Dec 2019, 12:25 pm
Tom Cotton (R-Ark.) for a discussion on The Global Hostage Act. [read post]
23 Jul 2021, 11:20 am
Sax & Sarah R. [read post]
23 Mar 2011, 6:26 am
Breeden, 2010 ONCA 547 and Banro Corporation v. [read post]
6 Dec 2017, 1:19 pm
C-14—C-15. [read post]
2 Apr 2019, 6:50 am
In Barrick Gold Corp. v. [read post]
What's so bad about "business method" patents? Small PR firms "goosed" by a patent on press releases
21 Jul 2010, 5:52 pm
Lead inventor on the patent-in-suit, Eileen C. [read post]
9 Aug 2018, 3:12 pm
Not well described in the IP context w/r/t these norms. [read post]
14 May 2012, 4:33 am
’ Graham Smith, writing on his Cyberleagle blog, provides a detailed run-down of the implications for internet publication. [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First… [read post]
4 Jul 2018, 1:30 pm
R. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
6 Oct 2011, 6:02 pm
They became part of the “corporate offensive” against activism[6] in response to the increase of American citizens speaking out on environmental and other social issues.[7] This phenomenon migrated to other jurisdictions such as Canada and Australia due to a similar rise in activism. [read post]
16 May 2008, 8:03 am
– Brdo: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 16 June / 1 July:US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - San Francisco / New York: (Patent Docs), 17-20 June: US BIO international convention – San Diego: (Patent Docs), 18-20 June / 9-11 July: US PLI: ‘Fundamentals of patent prosecution 2008: A… [read post]
28 Dec 2023, 9:05 pm
” President Joseph R. [read post]
